| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Applicant proposed research projects | |||||||||||||||||||||||||
2 | Name of Supervisor | Supervisor's email | Research area of interest | Name of Laboratory/Research Unit | Requirement | |||||||||||||||||||||
3 | Nanteetip Limpeanchob | nanteetipl@nu.ac.th | Pharmacological activity testing of natural products, herbal medicines, nutraceuticals, or dietary supplements using in vitro enzymatic assays and/or cell culture–based assays. Current research interests focus on metabolic syndrome, including diabetes, obesity, and hypercholesterolemia. | Pharmacology research Unit and Animal cell culture research unit | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
4 | Teerapon Dhippayom | teerapond@nu.ac.th | Evidence synthesis of helath intervetnions using a meta-analysis and network meta-analysis. The areas of interest included diabetes, repiratory tract disorders (asthma and COPD), warfarin management, pharmacy services, adherence promoting interventions, and telemedicine. | TRUES (The Research Unit of Evidence Synthesis) Website: https://phadb.pha.nu.ac.th/trues | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
5 | Prof.Jarupa Viyoch | jarupav@nu.ac.th | Health product development for antiaging | biomaterials & Regenerative Medicine Research Unit | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
6 | Assoc.Prayuth Poowaruttanawiwit | yuth_pu@hotmail.com | Innovation in Medical and Pharmaceutical Care Research and Deveopment focusing on ENT disease | Innovation in Medical and Pharmaceutical Care Research and Deveopment Research Unit | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
7 | Assistant Professor Worawut Kriangkrai, PhD | wg.kriangkrai@gmail.com | Research focuses on oral drug delivery systems, polymer-based pharmaceutical technology, and cosmeceutical product development using advanced formulation and natural biopolymers. | Green Therapeutics and Advanced Biodelivery Unit | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
8 | Associate Professor Chuenjid Kongkaew | chuenjidk@nu.ac.th | Epidemiological and economic aspects of health products (conventional medicines, herbal medicines, cosmetics, diagnostic testing). Suggested research themes include medication adherence in non-communicable diseses; pharmacovigilance in health productsa range of research techniques, including systematic review and/or meta-analysis, epidemiological studies, clinical trials for testing interventions and qualitative research. Throughout the process, applicants will be supported by experienced mentors and collaborators who are committed to fostering growth, encouraging curiosity, and ensuring a meaningful learning experience. Whether you're refining your skills or exploring new research directions, you'll be part of a collegial environment that values both rigor and inclusivity. | Research Centre of Safety and Quality in Health (SQH) | Before submitting an application, prospective applicants are encouraged to initiate contact with the supervisor via email to discuss the scope and direction of the research project. This dialogue helps ensure mutual alignment of interests, fosters early collaboration, and allows applicants to tailor their proposal to the project's evolving needs. | |||||||||||||||||||||
9 | Neti Waranuch, Ph.D. | netiw@nu.ac.th | Topical product development | Cosmetics and Natural Products Research Center (CosNat) Website: https://cosnat.pha.nu.ac.th/ | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
10 | Assoc.Prof. Nilawan Upakdee | nilawanu@nu.ac.th | Health Economics and Outcomes Research (HEOR), Health Technology Assessment (HTA) | Research Centre of Safety and Quality in Health (SQH) | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
11 | Assistant Professor Supawadee PARHIRA, Ph.D. | supawadeep@nu.ac.th | Natural prodcut chemistry, Phytochemistry, Standardization, Alternative medicines, anticancer activity, antiinflammatory and antioxidant activity | Pharmaceutical Technology II | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
12 | Associate Professor Waree Tiyaboonchai | wareet@nu.ac.th | Delivery system for drugs, cosmetics, and nutraceuticals | Pharmaceutical Technology | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
13 | Sudaporn Wongwan | sudapornk@nu.ac.th | Pharmaceutical analysis (development and validation: CE and HPLC), Chiral sparations, Drug quality control, Extemporaneous preparations, Analysis of Cosmetics, Nutricosmetics, and Natural products. | Pharmaceutical Analysis. | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
14 | Jira Jongcharoenkamol | jiraj@nu.ac.th | Medicinal chemistry, Organic synthesis, Green chemistry | Chemical Biology and Drug Discovery | Applicant must contact the supervior to discuss the scope of research project through email before submit the application. | |||||||||||||||||||||
15 | ||||||||||||||||||||||||||
16 | ||||||||||||||||||||||||||
17 | ||||||||||||||||||||||||||
18 | ||||||||||||||||||||||||||
19 | ||||||||||||||||||||||||||
20 | ||||||||||||||||||||||||||
21 | ||||||||||||||||||||||||||
22 | ||||||||||||||||||||||||||
23 | ||||||||||||||||||||||||||
24 | ||||||||||||||||||||||||||
25 | ||||||||||||||||||||||||||
26 | ||||||||||||||||||||||||||
27 | ||||||||||||||||||||||||||
28 | ||||||||||||||||||||||||||
29 | ||||||||||||||||||||||||||
30 | ||||||||||||||||||||||||||
31 | ||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||
33 | ||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | ||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |